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Received April 16, 2013; accepted April 19, 2013AbstractSince the first human infection with influenza A (H7N9) viruses have been identified in Shanghai on March 31, 2013, the latest variant of the
avian flu virus has spread across four Chinese provinces recently. Human infections with avian influenza are rare and this is the first time that
human infection with a low pathogenic avian influenza A virus has been associated with fatal outcome. To date (May 5th, 2013), China had
reported 128 confirmed H7N9 infections in human, among 27 died. Most reported cases have severe respiratory illness resulting in severe
pneumonia and in some cases have died. No evidence of sustained human-to -humans at this time, however, there is one family cluster with two
confirmed cases for which human-to-human transmission cannot be ruled out. Recent evidence showed that the gene sequences of this novel
H7N9 virus is primarily zoonotic and may be better adapted than other avian influenza viruses to infect human. Effective global infection control
is urgently needed, and further surveillance and analyses should be undertaken to identify the source and mode of transmission of these viruses.
Copyright  2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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On March 31, 2013, a novel Avian-origin influenza A
(H7N9) virus infection has been identified in Shanghai1 and
this is the first time that human infection with novel avian
influenza A virus has been associated with a fatal outcome.2
Influenza is an acute, usually self-limited, febrile illness
caused by infection with influenza type A or B virus that
occurs in outbreaks of varying severity almost every winter.3
However, they always pose a pandemic threat, since the vi-
ruses may adapt to humans. The primary risk factor for human
infection appears to be direct or indirect exposure to infected
live or dead animals or contaminated environment. In 1997,
the highly pathogenic H5N1 avian influenza virus (AIV) was
first transmitted from birds to humans in Hong Kong.4 This* Corresponding author. Dr. Ren-Bin Tang, Department of Pediatrics, Taipei
Veterans General Hospital, 201, Section, 2, Shih-Pai Road, Taipei 112, Taiwan,
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http://dx.doi.org/10.1016/j.jcma.2013.04.003new H7N9 AIV (Fig.1)5 is a subgroup among the larger group
of H7 viruses, which normally circulate among birds.6 Human
infections with other subgroups of H7 influenza viruses
(H7N2, H7N3, and H7N7) have previously been reported in
the Netherlands, Italy, Canada, United States of America,
Mexico and the United Kingdom.7 While highly pathogenic
H5N1 and H7 viruses may cause fatal disease in people, all
human infections caused by low pathogenic H7 viruses so far
have been mild. It is therefore our concern to see that how this
new low pathogenic avian virus H7N9 virus can be lethal in
humans.
2. Virology
Influenza A viruses are further divided into subtypes on the
basis of their hemagglutinin (H1 to H17) and neuraminidase
(N1 to N10) activity.8 A third integral membrane protein, the
M2 protein, is also present in small amount on the viral en-
velope3 This novel avian influenza A virus (H7N9) differs
genetically from A (H7) and A (N9) viruses that have beenhinese Medical Association. All rights reserved.
Fig.1. Electron micrograph of new influenza A ( H7N9) virus from China.
Source: CDC USA Public Health Image Libery. ID#15673/ Cynthia S. Gold-
smith and Thomas Rowe.5
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leagues reported that the H7N9 viruses identified in the first
three patients were of avian origin and all the internal gene
segments were closely related to A/brambling/Beijing/16/
2012-like viruses (H9N2). The neuraminidase (NA) gene was
closely related to A/wild bird/Korea/A14/2011 (H7N9, sub-
type KO14) and the gene encoding hemagglutinin (HA) shared
the highest identity with A/duck/ Zhejiang/12/2011(H7N3,
subtype ZJ12).9 The affinity of the influenza virus to different
sialyl-sugar structures is an important determinant of range
and pathogenicity in the viral host.10,11 Q226L in the HA
protein, which was first reported in H7 field viruses, as well as
H5 subtypes, was expected to bind strongly to alpha 2-6
human like receptors.9 Researchers reported that a laboratory-
generated Q226L mutation at the 210-loop of HA could
change the receptor binding of avian origin to a human-type
receptor binding and might increase the ability of the virus
to be transmitted by air.12,13 Since human influenza viruses
preferentially bind to alpha 2-6 receptors, they might have
greater ability to infect mammalian species.13. Epidemiology
Human infections with avian influenza are rare and
occurred most commonly after exposure to infected poultry.
The novel rearranged H1N1 influenza virus ( the swine-origin
influenza virus) outbreak emerged from Mexico and the
United stated in April 2009, then pandemic outbreak in all
over the world.14 Chan et al reported that there were certain
risk groups of hospital personnel that may contract the disease.
Their data showed that the seropositive rate (SPR) of anti-
bodies against the pandemic (H1N1) 2009 virus in certain riskgroups and most infected individuals probably only have mild
or even subclinical symptoms.14 H7 virus infection in humans
is uncommon, however, this is the first time that this avian
influenza subtype (H7N9) is found in people. To date (May
5th, 2013), China had reported 128 laboratory confirmed
human cases from eight provinces: Anhui (4), Jiangsu (27),
Zhejiang (46), Henan (4), Shandong (2), Jiangxi (5), Fujian
(4), and Hunan (2), and two municipalities, Beijing (1) and
Shanghai (33), including 27 fatal cases reported from Jiangsu
(6), Zhejiang (6), Anhui (1), Jiangxi (1) and Shanghai (13).15
In Taiwan, a cumulative total of 295 suspected H7N9 cases
have been reported to Taiwan Centers for Disease Control
(CDC) and infection with avian influenza A ( H7N9) has been
confirmed in one case, 3 cases are still pending results and the
possibility of H7N9 infection has been ruled out in the
remaining cases.15 This virus is very different from other
H7N9 viruses previously found in birds. Most H7 viruses
identified worldwide in wild birds and poultry are low path-
ogenic avian influenza A (LPAI) viruses. The source of
infection and the mode of transmission are currently unknown.
Li Q et al reported that 77% of the first 82 H7N9 patients had
some animal exposure, however, some cases have not had such
contact.16 Taiwan Central Epidemic Command Center
(CECC) obtained that 139 people who have come into contact
with the confirmed case, including 3 close contacts, 26 regular
contacts (past the 10-day incubation period), and 110 health-
care workers. The public health authority conducted to all
contacts for “Self-Health Management Advice for H7N9
Influenza” and will be following up with them closely until the
period of voluntary contact tracing is lifted. When they
develop influenza-like illness symptoms such as fever and
cough, the public health authority will voluntarily assist the
individual in seeking medical attention.17 The possibility of
animal-to-human or person-to-person transmission is being
investigated. World Health Organization (WHO) issues first
risk assessment on China’s H7N9 outbreak on April 13, 2013,
because two confirmed cases have been possibly associated
with family clusters, in which one and two additional family
members, respectively, developed severe pneumonia. Close
contacts are being monitored but the agency said that no
samples that have undergone polymerase chain reaction (PCR)
testing have been found positive for the virus.1,18
4. Clinical characteristics
The main clinical feature among most patients is severe
pneumonia. Symptoms include fever, cough and shortness of
breath.7 In humans, LPAI (H7N2, H7N3, H7N7) virus in-
fections have caused mild to moderate illness (conjunctivitis
and/or upper respiratory tract symptoms). However, high
pathogenic avian influenza (HPAI) A (H7N3, H7N7) virus
infections may cause mild to severe or even fatal illness.19 Gao
and colleagues reported that the clinical features in three pa-
tients with H7N9 virus infection were fulminant pneumonia,
respiratory failure, acute respiratory distress syndrome
(ARDS), septic shock, multiorgan failure, rhabdomyolysis,
and encephalopathy.9 The first case (H7N9) reported in
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after returning from Suchow, Jiangsu Province, China on
April 9, 2013. The patient still had high fever on April 16,
2013 and sought medical attention, two throat- swab speci-
mens tested negative for H7N9 with real-time PCR on April
17 and April 20. He was then transferred to Medical Center on
April 20 due to progressive dyspnea with progressive bilateral
lower-lung consolidation on chest radiograph. Endotracheal
intubation and mechanical ventilator support and extracorpo-
real membrane oxygenation were used due to respiratory
failure. Then very high viral loads were found in the two
sputum specimens and one throat-swab specimen collected on
April 20 and April 22.20 However, information of the full
disease spectrum that influenza A (H7N9) virus infection
might cause is still very limited.4.1. Case Investigation and testingIn United states, Centers for Disease Control and Preven-
tion (CDC) recommended that patients with illness compatible
with influenza who recently travel to countries where
human cases of novel influenza A (H7N9) virus infection have
recently been detected, who with recent contact
with confirmed human cases of infection with novel influenza
A (H7N9) virus and who with recent direct or close contact
with animals (such as wild birds, poultry, or pigs) or where
influenza A (H7N9) viruses are known to be circulating in
animals, should be candidates for reverse-transcription poly-
merase chain reaction (RT-PCR) testing for influenza. De-
cisions about diagnostic testing for influenza using RT-PCR
should be made using available clinical and epidemiologic
information, and additional suspected cases of influenza A
(H7N9) virus infection should also be tested. Commercially
available rapid influenza diagnostic tests (RIDTs) may not
detect avian or variant influenza A viruses in respiratory
specimens. Therefore, when RIDTs are positive for influenza
A and there is concern for novel influenza A virus infection,
respiratory specimens should be collected and sent for RT-
PCR testing at a well equipped laboratory. All unsubtype-
able influenza A virus specimens should be submitted to CDC
immediately for additional diagnostic testing. At this time,
confirmatory testing for avian influenza A (H7N9) will be
conducted at CDC.21
CECC has continued to strengthen surveillance and fever
screening of travelers arriving from China, especially areas
with ongoing outbreaks of human infection with avian influ-
enza A (H7N9), including Shanghai, Jiangsu, Zhejiang, Anhui,
Beijing, Henan and Shandong. All the physicians are reminded
to report suspected cases to the health authority within 24
hours of detection according to the relevant regulation as
follow: before the infection is confirmed (1) isolate and hos-
pitalized the suspect case-patient with severe respiratory in-
fections, (2) asked the suspect case-patient with mild
symptoms to conduct self-health management and put on a
surgical mask and provided with thorough health education. In
addition, specimens should collect from the patient for labo-
ratory testing and administering of antiviral drugs if necessary.When human infection with avian influenza A (H7N9) is
confirmed, an appropriate hospital for isolation and treatment
will be determined by the Regional Commander of CECC.174.2. TreatmentNo experience yet, however, laboratory testing conducted
in China showed that influenza A (H7N9) viruses are sensitive
to neuraminidase inhibitors (oseltamivir and zanamivir) but
resistant to other antiviral drugs amantadine and rimanta-
dine.2,6,7 When these drugs are given early in the course of
illness, they have been found to be effectively against seasonal
influenza virus and influenza A (H5N1) virus infection.
5. Prevention
Currently, the best way to prevent infection with avian
influenza A viruses is to avoid the sources of exposure.
Advised people who work with poultry or who response to
avian influenza outbreak to use of appropriate personal pro-
tective equipment and careful attention to hand hygiene.22
There is no vaccine available for the prevention of influenza
A (H7N9) infections at this time. Although both the source of
infection and the mode of transmission are uncertain, it is
prudent to follow basic hygienic practices to prevent infection.
They include hand and respiratory hygiene and food safety
measures.75.1. Hand hygiene Wash your hands before, during, and after you prepare
food; before you eat; after you use the toilet; after
handling animals or animal waste; when your hands are
dirty; and when providing care when someone in your
home is sick.75.2. Respiratory hygiene Cover your mouth and nose with a medical mask, tissue, or
a sleeve or flexed elbow when coughing or sneezing; throw
the used tissue into a closed bin immediately after use;
perform hand hygiene after contact with respiratory
secretions.75.3. Food safety measure Meat products can be safely consumed provided that these
items are properly cooked and properly handled during
food preparation. The consumption of raw meat and un-
cooked blood-based dishes is a high-risk practice and
should be strongly discouraged.75.4. VaccinationCDC and WHO recommended HPAI poultry outbreak re-
sponders should receive seasonal influenza vaccination annually
and take prophylactic antiviral medication during response.
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infection with avian influenza Aviruses, they can reduce the risk
of co-infection with human and avian influenza A virus.22
Taiwan CDC also recommended that people who work in the
inspection and quarantine sectors, medical and healthcare
personnel and peoplewho frequently visit areas at risk for H5N1
influenza infection to get vaccinated against H5N1.23 When a
critical portion of a community is immunized, most members of
the community are protected , known as “herd” immunity.24 The
first step in development of a vaccine is the selection of candi-
date viruses that could go into vaccine production. WHO, in
collaboration with partners, will continue to characterize
available influenza A (H7N9) viruses to identify the best
candidate viruses.7 The influenza H7N9 A/Anhui/1/2013 strain
has been proposed to be one of the candidate vaccine strains
since it grows to a very high titer in eggs. Enhanced protective
measures should be taken when dealing with these viruses, and
increased surveillance and analyses of theseviruses are needed.9
In conclusion, rapid detection and characterization of novel
influenza viruses remain a critical component of national ef-
forts to prevent H7N9 infection. Clinicians should consider the
possibility of H7N9 virus infection in persons with respiratory
illness and a travel or exposure history. All human infections
with animal influenza viruses deserve close attention, not only
because of the risk of death in individual people, but also
because if these viruses become capable of spreading from
human to human, they could spark a pandemic. However,
whether the influenza A (H7N9) virus could actually cause a
pandemic is still uncertain. First-line healthcare providers
should be highly aware of appropriate infection prevention
measures for patients under investigation.References
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